Investor Info
Our Presentation
Cap Table
MustGrow is publicly traded (TSXV:MGRO; OTCQB:MGROF; FRA:0C0) agricultural biotech company focused on providing natural science-based biological solutions for high value crops, including fruit & vegetable cultivation.
| CAPITAL STRUCTURE | |
|---|---|
| Basic Shares Outstanding | 51,640,610 |
| Options/RSU's/DSU's | 4,076,857 |
| Warrants | - |
| Fully-Diluted Shares Outstanding | 55,717,467 |
| Insider / Advisor Ownership (21%) | 10,845,232 |
| Average Volume (3 month) | 40,000 |
| Previous Capital Spent | C$26,000,000 |
| Cash Position | C$3,100,000 |
| Debt | C$800,000 |
FINANCIAL STATEMENTS
2024
Financials
2023
Financials
Q3-2024
2022
Financials
2021
Financials
ANNUAL INFORMATION FORM
News Releases
MustGrow Biologics Announces Proposed Private Placement of Units for Approximately $2 million
MustGrow Biologics Announces Proposed Private Placement of Units for Approximately $2 million SASKATOON, Saskatchewan, Canada, December 11, 2024 – MustGrow Biologics Corp. (TSXV:MGRO) (OTC:MGROF) (FRA:0C0) (the "Company" or "MustGrow") is pleased to announce a...
MustGrow Biologics Signs Non-Binding Term-Sheet for Acquisition of NexusBioAg
MustGrow Biologics Signs Non-Binding Term-Sheet for Acquisition of NexusBioAg SASKATOON, Saskatchewan, Canada, November 27, 2024 – MustGrow Biologics Corp. (TSXV:MGRO) (OTC:MGROF) (FRA:0C0) (the "Company" or "MustGrow") is pleased to announce the signing of a...
MustGrow Provides 2024 Pipeline Update
MustGrow Provides 2024 Pipeline Update MustGrow transitions from R&D to commercialization. TerraSanteTM biofertility product manufacturing and sales has commenced, with potential initial sales ramp-up in 2025 and 2026. Commercialization of TerraMGTM soil...